DNA methylation of SSPN is linked to adipose tissue distribution and glucose metabolism

DNA methylation is a crucial epigenetic mechanism in obesity and fat distribution. We explored the Sarcospan (SSPN) gene locus by using genome‐wide data sets comprising methylation and expression data, pyro‐sequencing analysis in the promoter region, and genetic analysis of an SNP variant rs718314, which was previously reported to associate with waist‐to‐hip ratio. We found that DNA methylation influences several clinical variables related to fat distribution and glucose metabolism, while SSPN mRNA levels showed directionally opposite effects on these traits. Complete DNA methylation of the SSPN promoter construct suppressed the gene expression of firefly luciferase in MCF7 cells. Moreover, rs718314 was associated with waist and with DNA methylation at CpG sites. Our data strongly support the role of the SSPN locus in body fat composition and glucose homeostasis, and suggest that this is most likely the result of changes in DNA methylation of SSPN in adipose tissue.—Keller, M., Klös, M., Rohde, K., Krüger, J., Kurze, T., Dietrich, A., Schön, M. R., Gärtner, D., Lohmann, T., Dreßler, M., Stumvoll, M., Blüher, M., Kovacs, P., Böttcher, Y. DNA methylation of SSPN is linked to adipose tissue distribution and glucose metabolism. FASEB J. 32, 6898–6910 (2018). www.fasebj.org

[1]  C. Ling,et al.  Genome-wide DNA promoter methylation and transcriptome analysis in human adipose tissue unravels novel candidate genes for obesity , 2016, Molecular metabolism.

[2]  Y. Böttcher,et al.  Many obesity-associated SNPs strongly associate with DNA methylation changes at proximal promoters and enhancers , 2015, Genome Medicine.

[3]  Jamie L. Marshall,et al.  Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin. , 2015, Human molecular genetics.

[4]  Ivan Smirnov,et al.  Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser , 2015, Nature Biotechnology.

[5]  M. Stumvoll,et al.  Adipose tissue depot specific promoter methylation of TMEM18 , 2014, Journal of Molecular Medicine.

[6]  C. Cucarella,et al.  Stable SREBP-1a knockdown decreases the cell proliferation rate in human preadipocyte cells without inducing senescence. , 2014, Biochemical and biophysical research communications.

[7]  E. McNally,et al.  Modifying muscular dystrophy through transforming growth factor‐β , 2013, The FEBS journal.

[8]  Mary K. Wojczynski,et al.  Genome-Wide Association of Body Fat Distribution in African Ancestry Populations Suggests New Loci , 2013, PLoS genetics.

[9]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[10]  Jamie L. Marshall,et al.  Sarcospan: a small protein with large potential for Duchenne muscular dystrophy , 2013, Skeletal Muscle.

[11]  Jamie L. Marshall,et al.  Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration , 2012, The Journal of cell biology.

[12]  David Haussler,et al.  The Human Epigenome Browser at Washington University , 2011, Nature Methods.

[13]  Peter A. Jones,et al.  DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. , 2011, Human molecular genetics.

[14]  Thomas Meitinger,et al.  Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution , 2010, Nature Genetics.

[15]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[16]  E. Mariman,et al.  Adipocyte extracellular matrix composition, dynamics and role in obesity , 2010, Cellular and Molecular Life Sciences.

[17]  D. Freyssenet,et al.  A New Role for Sterol Regulatory Element Binding Protein 1 Transcription Factors in the Regulation of Muscle Mass and Muscle Cell Differentiation , 2009, Molecular and Cellular Biology.

[18]  J. Zierath,et al.  Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. , 2009, Cell metabolism.

[19]  Laura J. Scott,et al.  Edinburgh Research Explorer Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution , 2022 .

[20]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[21]  Jamie L. Marshall,et al.  Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complex , 2008, The Journal of cell biology.

[22]  B. Wolffenbuttel,et al.  Characterization of the Human Visceral Adipose Tissue Secretome*S , 2007, Molecular & Cellular Proteomics.

[23]  M. Rehli,et al.  Functional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector , 2006, Epigenetics.

[24]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[25]  K. Campbell,et al.  Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex* , 1997, The Journal of Biological Chemistry.

[26]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[27]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.